Blood Pressure and Hypertension Studies
Blood Pressure and Hypertension Studies is a research topic within Cardiology and Cardiovascular Medicine. Science Explorer counts 61k research works in it since 1950. 15.5% of them reached the world's top 10% most cited for their field and year.
This cluster of papers focuses on the management of hypertension, including the use of antihypertensive drugs, cardiovascular risk factors, renal denervation, and the impact of hypertension on conditions such as diabetes mellitus. It also addresses the global burden of hypertension, provides clinical guidelines for hypertension management, and explores the relationship between hypertension and cardiovascular events.
- Hypertension
- Blood Pressure
- Cardiovascular Disease
- Antihypertensive Drugs
- Renal Denervation
- Diabetes Mellitus
- Global Burden
- Clinical Guidelines
- Cardiovascular Events
- Risk Factors
- Research works
- 61k fractional, since 1950
- In the world top 10%
- 9.4k per year above
- Top-10% rate
- 15.5% share of its works in the world top 10%
- Growth, 2013–17 → 2018–22
- +18% the tick is no change
This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.
Which countries lead Blood Pressure and Hypertension Studies research?
By volume, the United States and China publish the most (1.9k and 990 works in 2022–2025).
By volume, 2022–2025
- 1 United States 1.9k works
- 2 China 990 works
- 3 India 515 works
- 4 United Kingdom 374 works
- 5 Japan 373 works
- 6 Italy 316 works
- 7 Brazil 309 works
- 8 South Korea 248 works
- 9 Spain 246 works
- 10 Russia 238 works
How concentrated that is
The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.
Shares of the rows listed above, not of the whole node.
Which institutions lead Blood Pressure and Hypertension Studies research?
By volume in 2022–2025, Jichi Medical University publishes the most Blood Pressure and Hypertension Studies research, followed by National and Kapodistrian University of Athens and Chinese Academy of Medical Sciences & Peking Union Medical College.
By volume, 2022–2025
- 1 Jichi Medical UniversityJapan 44 works
- 2 National and Kapodistrian University of AthensGreece 43 works
- 3 Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina 37 works
- 4 University of North Carolina at Chapel HillUnited States 37 works
- 5 Aristotle University of ThessalonikiGreece 35 works
- 6 Johns Hopkins UniversityUnited States 34 works
- 7 University of Milano-BicoccaItaly 31 works
- 8 Harvard UniversityUnited States 30 works
- 9 Yale UniversityUnited States 26 works
- 10 Imperial College LondonUnited Kingdom 25 works
Who are the leading researchers in Blood Pressure and Hypertension Studies?
The most-cited researchers publishing on Blood Pressure and Hypertension Studies include Giuseppe Remuzzi, George A. Mensah and Mayowa Owolabi.
- 1 Giuseppe Remuzzi Italy 8.1k citations
- 2 George A. Mensah United States 6.8k citations
- 3 Mayowa Owolabi Nigeria 6.5k citations
- 4 Norberto Perico Italy 6.1k citations
Ranked by citations received across their whole record, among researchers with at least three works on this topic.
Where is Blood Pressure and Hypertension Studies research done?
The largest centres of Blood Pressure and Hypertension Studies research in 2022–2025 are Beijing (China), Seoul (South Korea), London (United Kingdom) and Moscow (Russia). Among places with at least 20 works in it, it is an unusually large share of all research in Shimotsuke, Winston-Salem and Thessaloniki.
Largest cities, 2022–2025
Where it is the local speciality
- ShimotsukeJP · 44.2 works55×
- Winston-SalemUS · 25.8 works7.4×
- ThessalonikiGR · 57.4 works7.3×
Location quotient: how much more of its research is in Blood Pressure and Hypertension Studies than the world average.
Where is the best place to study Blood Pressure and Hypertension Studies?
Among universities, judged by research, University of Milano-Bicocca, Jichi Medical University and National and Kapodistrian University of Athens score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.
One dot per university in the table below. The upper left is the interesting corner: small places doing unusually strong work.
| # | University | Score | Top 10% | Specialisation | Works | Growth |
|---|---|---|---|---|---|---|
| 1 | University of Milano-BicoccaItaly | 71.4 | 24.5% | 11.7× | 31 | +17.8% |
| 2 | Jichi Medical UniversityJapan | 70.8 | 23.7% | 54.8× | 44 | +10.3% |
| 3 | National and Kapodistrian University of AthensGreece | 70.6 | 10.9% | 9.2× | 43 | +195.0% |
| 4 | Aristotle University of ThessalonikiGreece | 59.7 | 9.8% | 7.5× | 35 | +147.4% |
| 5 | Harvard UniversityUnited States | 56.7 | 28.8% | 2.6× | 30 | +31.4% |
| 6 | Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina | 56.4 | 23.6% | 4.2× | 38 | +48.2% |
| 7 | University of GondarEthiopia | 55.7 | 25.7% | 6.3× | 9 | +502.1% |
| 8 | Dow University of Health SciencesPakistan | 55.3 | 15.9% | 11.1× | 13 | — |
| 9 | Tulane UniversityUnited States | 55.1 | 26.2% | 7.2× | 17 | -10.5% |
| 10 | Johns Hopkins UniversityUnited States | 55.0 | 24.9% | 3.4× | 34 | +34.7% |
Universities only. Score blends excellence (30%), specialisation (25%), size (20%), growth (15%) and international reach (10%), 2015–2022; growth compares 2010–14 with 2015–19.
Is Blood Pressure and Hypertension Studies research growing?
Output in 2018–2022 was 18% higher than in 2013–2017, peaking in 2023. The fastest-growing topics are Blood Pressure and Hypertension Studies.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Which topics inside it are moving
Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.